Global Perinatal Infections Market – Industry Trends and Forecast to 2029

Perinatal Infections Market Analysis and Size

The global perinatal infections market is expected to witness significant growth during the forecast period.  Rising prevalence of perinatal infections worldwide and emerging markets are the factors responsible for the growth of this market. The market is on the rise due to increase in the surgical procedures, R&D activities funded by government and rise in the population in this region. Growing cases of HIV-AIDS & hepatitis C drives the perinatal infections market. COVID-19 also had a major impact on the market growth.

 Data Bridge Market Research analyses a growth rate in the global perinatal infections market in the forecast period 2022-2029. The expected CAGR of global perinatal infections market is tend to be around 7.0% in the mentioned forecast period. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Perinatal infections are caused by a virus or bacteria that can be passed from mother to foetus during the delivery or pregnancy time. Maternal infection may cause sever disability or complication to the baby because mother may or may not experience any active symptoms of infection during pregnancy time.

Report Scope and Market Segmentation

Global Perinatal Infections Market Dynamics

Drivers

• Increased Cases of HIV

The increasing prevalence of human immunodeficiency virus (HIV) is expected to boost the market's growth. Around 38.4 million people were living with HIV globally at the end of 2021.  

Opportunities

• Increasing Incidence of Perinatal Infections

Perinatal infection occurs in approximately 1/1000 births most commonly due to Group B Streptococcus or E.coli. These organisms can cause infections that are relatively common cause of stillbirth and can also cause serious neonatal morbidity, with early-onset thrombocytopenia occurring in around 50% of cases. This creates more opportunity to the market

• Increasing Demand for Retail Pharmacies

Opportunities for market growth are created by the rise in the number of perinatal infections treatments supplied through retail pharmacies and the rise in the number of retail pharmacies in developed nations. Patients also favour retail pharmacies because they are convenient for acquiring medications.

 Restraints/Challenges

• Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global perinatal infections market over a forecast period.

• High Cost

The huge expenditure associated with perinatal infections medications surely hamper the market growth.

This global perinatal infections market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global perinatal infections market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Perinatal Infections Market       

Considering the present scenario, COVID-19 has left a major global public health crisis that has impacted practically every business. Its long-term repercussions are expected to grow industry growth during the forecast period.

Although during the pandemic, the attention was driven towards the COVID-19 patients majorly and hospitals and clinics were occupied with these patients but in the post-pandemic era, the biotechnology and pharmaceutical industries are expected to witness a huge growth in the future, as research and treatments are drifting again towards the normal patients. Thus, this will significantly impact the global perinatal infections market.

Global Perinatal Infections Market Scope

The global perinatal infections market is segmented on the basis of treatment, diagnosis, infection type, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Infection Type

• Cytomegalovirus Infection
• Enterovirus Infection
• Genital Herpes
• Gonorrhoea
• Human Immunodeficiency Virus
• Listeriosis Lymphocytic Choriomeningitis Virus
• Rubella
• Syphilis
• Varicella
• Others

Diagnosis

• Maternal Test
• Neonatal Test
• Others

Treatment

• Antibiotics
• Antiviral
• Antiretroviral
• Others

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Perinatal Infections Market Regional Analysis/Insights

The global perinatal infections market is analysed and market size insights and trends are provided by treatment, diagnosis, infection type, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global perinatal infections market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global perinatal infections market throughout the forecasted period due to rising prevalence of neonatal neurological disorders

Asia-Pacific dominates the market due to increased WHO & government awareness programs and increased zika virus infection in Asian countries.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Perinatal Infections Market Share Analysis

The global perinatal infections market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global perinatal infections market

Key players operating in the global perinatal infections market include:

• Merck KGaA (Germany)
• Beckman Coulter Inc. (U.S.)
• BIOMERIEUX (France)
• Bio-Rad Laboratories, Inc (U.S.)
• Danaher (U.S.)
• Hologic Inc. (U.S.)
• Gilead Sciences, Inc. (U.S.)
• Emcure Pharmaceuticals Limited. (India)
• Cipla Inc. (U.S.)
• Hetero (India)
• Bausch Health Companies Inc. (Canada)
• Johnson & Johnson Private Limited (U.S.)
• Mylan N.V. (U.S.)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• Novartis AG (Switzerland)
• Sun Pharmaceutical Industries Ltd. (India)
• Aurobindo Pharma (India)
• Biocon (India)
• Bristol-Myers Squibb Company (U.S.)
• GSK plc (UK)
• Shanghai Desano Pharmaceuticals Co., Ltd. (China)

SKU-53838